The c.967G>A variant in MYOC is a missense variant predicted to cause substitution of Glutamic Acid by Lysine at amino acid 323 (p.Glu323Lys). This variant was not found in any genetic ancestry group of gnomAD (v4.1.0), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a genetic ancestry group of at least 10,000 alleles. The REVEL score = 0.759, which was within the 0.644-0.772 range for PP3, predicting a damaging effect on MYOC function. The Glu323Lys protein had increased insolubility, instability and reduced secretion levels compared to wild type myocilin protein in this these studies (PMIDs: 16466712, 21612213, 23129764). The assays met the OddsPath threshold for PS3_Moderate (> 4.3). This protein has also been assessed in these other studies (PMIDs: 11004290, 10545602, 15069026, 16297911), however, the same level of evidence was not met. 10 segregations in 1 family, with juvenile open angle glaucoma, have been reported (PMID: 9772276), which fulfilled PP1_Moderate (≥ 5 meioses in ≥ 1 family, but not the ≥ 7 meioses in > 1 family for the strong criterion). 5 probands with juvenile or primary open angle glaucoma have been reported carrying this variant (PMIDs: 9772276, 12616399, 37485465), which met PS4_Supporting (≥ 2 probands). In summary, this variant met the criteria to receive a score of 7 and to be classified as likely pathogenic (likely pathogenic classification range 6 to 9, adapted from PMID: 32720330) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v2.0.0, 5 Dec 2024): PS3_Moderate, PP1_Moderate, PP3, PS4_Supporting, PM2_Supporting